Injectafer denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Injectafer

UnitedHealthcare requires prior authorization (PA) for Injectafer (ferric carboxymaltose) because it is a higher-cost intravenous iron product. The PA process is UHC's mechanism for confirming that specific clinical criteria are met before it agrees to pay. A denial at the PA stage — or a denial of a claim because PA was not obtained — means either that the PA was not submitted, was submitted without sufficient documentation, or that UHC's reviewer determined the clinical criteria were not satisfied based on the information provided.

## Why This Denial Is Appealable

A PA denial is not a final word. It is a determination made, often by a non-treating clinician, based solely on the documentation submitted. If the clinical picture supports Injectafer and the documentation was incomplete or misread, an appeal with a complete record routinely succeeds. If PA was never sought because the treating clinician or facility was unaware of the requirement, a retroactive PA or administrative appeal may still be available.

## Your Federal Appeal Rights

• Internal appeal: File a written appeal of the PA denial. UHC must have a treating physician review any denial that involves medical judgment.
• Peer-to-peer review: Your prescriber has the right to request a peer-to-peer conversation with UHC's reviewing clinician before or after the denial. This call frequently resolves PA denials without a formal appeal.
• External review (ACA §2719): If the internal appeal is denied, request independent external review.
• ERISA §503: For self-funded employer plans, you are entitled to the full claims file and all clinical review criteria.
• Expedited process: For urgent infusions, request expedited PA review — UHC is required to respond on an accelerated timeline.
• Timeline: Request external review within four months of the final internal adverse determination.

## Documentation to Gather

1. Completed PA request package: Confirm the PA form was submitted with diagnosis codes, the prescriber's NPI, the requested product, and all supporting clinical notes. 2. Oral iron trial documentation: Dates, products, duration, and documented outcomes of any prior oral iron therapy. 3. Underlying diagnosis records: Lab results, clinical notes, endoscopy or imaging reports, specialist letters establishing the cause and severity of iron deficiency. 4. Prescriber medical-necessity letter: A narrative letter from the treating clinician addressing each of UHC's PA criteria by name, with chart citations. 5. UHC PA criteria: Download UHC's published prior authorization criteria for Injectafer so every requirement is addressed in the submission.

## Criteria-Mapping Structure

Before submitting the appeal, obtain UHC's PA criteria document. Create a table: left column lists each PA criterion verbatim; right column provides the specific chart entry — date, clinician name, finding — that satisfies it. This table should be attached to the prescriber's medical-necessity letter. An appeal that systematically addresses every criterion is substantially less likely to be denied a second time. If the peer-to-peer option has not been used, exercise it in parallel with the written appeal.